since 2005, approximately 200,000
patients have been treated with our
first approved product, GEM 21S®, for
the treatment of periodontally related
bone defects. Augment Bone Graft
and GEM 21S are essentially
the same
products, both containing rhPDGF-BB
and ß-tricalcium phosphate (ß-TCP),
but with a different TCP particle size.
To date, each of these products has
demonstrated
a strong record of efficacy